Biotechnology Market Research Reports & Industry Analysis
Biotechnology is a rapidly evolving industry that holds immense potential for growth and innovation across a wide range of product applications and markets. At MarketResearch.com, we offer a variety of biotechnology market research reports that provide valuable insights and data on key market segments across the world.
Biotech Market Research to Fuel Business Growth
Our reports answer critical questions about the biotechnology market to help guide your business strategies. Our research covers:
- Current market performance, industry outlooks, and industry lifecycles
- Expert analysis of supply chains, products and services, market drivers and challenges, and major markets to watch
- Market share information, profiles of established and emerging players, discussion of key success factors, and financial benchmarking
- Insights into new technologies and patents, pipeline analysis, data on revenue fluctuations, and overviews of regulations & policies
Stay Ahead with our Biotechnology Industry Analysis
The biotechnology market is advancing at a fast pace, with new technologies and products emerging all the time. Our reports help businesses stay up to date on these changes and identify new opportunities for growth. With our trusted reputation and commitment to quality, MarketResearch.com is the ideal source for biotechnology market research reports written by experienced analysts with extensive knowledge of the industry. MarketResearch.com has been a trusted source for business intelligence for over 20 years, and our long-time clients include many leading companies in the life sciences. If you need assistance, our team of knowledgeable research specialists are always available to help expedite the process.
Biotechnology Industry Research & Market Reports
-
High-Resolution Melting Analysis
... by 2030, growing at a CAGR of 2.9% over the analysis period 2023-2030. Other Applications, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$31.1 Million by ... Read More
-
MRSA Drugs
... at a CAGR of 4.4% over the analysis period 2023-2030. Glycopeptides & Lipoglycopeptides, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$726.5 Million by the end ... Read More
-
NGS-Based RNA-Sequencing
... at a CAGR of 20.2% over the analysis period 2023-2030. Sequencing Platforms & Consumables, one of the segments analyzed in the report, is expected to record a 20.7% CAGR and reach US$5.1 Billion by the ... Read More
-
GMP Cell Banking Services
... reach US$2.2 Billion by 2030, growing at a CAGR of 15.0% over the analysis period 2023-2030. Biopharmaceutical Companies End-Use, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and ... Read More
-
Gynecological Cancer Drugs
... by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Cervical Cancer Drugs, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$10.3 Billion ... Read More
-
Nanomedicine
... of 9.8% over the analysis period 2023-2030. Regenerative Medicine Application, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$229.6 Billion by the end of the analysis ... Read More
-
Human Microbiome
... at a CAGR of 28.4% over the analysis period 2023-2030. Gastrointestinal Diseases, one of the segments analyzed in the report, is expected to record a 28.7% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases
... US$9.1 Billion in the year 2023, is expected to reach US$16.4 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.5 Billion While China ... Read More
-
Newborn Screening
... at a CAGR of 7.1% over the analysis period 2023-2030. Newborn Screening Consumables, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$1.4 Billion by the end ... Read More
-
Computational Biology
... at a CAGR of 18.1% over the analysis period 2023-2030. Contract Services, one of the segments analyzed in the report, is expected to record a 19.2% CAGR and reach US$20.1 Billion by the end of ... Read More
-
Humanized Mouse and Rat Model
... is expected to reach US$219.4 Million by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Oncology Application, one of the segments analyzed in the report, is expected to record a 8.1% ... Read More
-
Hydrophobic Interaction Chromatography
... a CAGR of 6.3% over the analysis period 2023-2030. Chromatography Resins, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$263.1 Million by the end of the ... Read More
-
Europe Next Generation Sequencing Market Report by Products (Instruments, Reagents & Consumables, and Services), Application (Diagnostics, Agriculture and Animal Research, Drug Discovery, Personalized Medicine and Genetic Screening, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), Country and Company Analysis 2024-2032
... Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), Country and Company Analysis 2024-2032 Europe Next Generation Sequencing Market Outlooks Next ... Read More
-
CRISPR Technology
... CAGR of 21.1% over the analysis period 2023-2030. Products Component, one of the segments analyzed in the report, is expected to record a 20.3% CAGR and reach US$6.1 Billion by the end of the analysis ... Read More
-
Mammalian Polyclonal IgG Antibody
... 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Metabolic Markers, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$532.1 Million by the ... Read More
-
Thrombin
... 3.8% over the analysis period 2023-2030. Bovine Thrombin, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$379.3 Million by the end of the analysis period. Growth ... Read More
-
Soft Tissue Allografts
... at a CAGR of 4.9% over the analysis period 2023-2030. Orthopedic Application, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Cold Plasma
... at a CAGR of 14.7% over the analysis period 2023-2030. Polymer & Plastics End-Use, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$1.7 Billion by the ... Read More
-
Capillary Electrophoresis
... CAGR of 6.0% over the analysis period 2023-2030. Academic Institutes & CROs End-Use, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$747.2 Million by the end ... Read More
-
Chromatography Instruments
... CAGR of 5.0% over the analysis period 2023-2030. Liquid Chromatography Systems, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$6.6 Billion by the end of the ... Read More
-
Biotech Business October 2024
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline. Read More
-
Combination Antibody Therapy
... by 2030, growing at a CAGR of 13.9% over the analysis period 2023-2030. Breast Cancer Application, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$215.4 Billion ... Read More
-
Genomics
... of 19.0% over the analysis period 2023-2030. Sequencing Technology, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$106.1 Billion by the end of the analysis period. ... Read More
-
PEGylated Proteins
... at a CAGR of 9.1% over the analysis period 2023-2030. PEGylated Protein Consumables, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$1.3 Billion by the end ... Read More
-
Synthetic DNA
... at a CAGR of 18.6% over the analysis period 2023-2030. Pharmaceuticals & Diagnostics Application, one of the segments analyzed in the report, is expected to record a 20.0% CAGR and reach US$4.5 Billion by the ... Read More
Research Assistance
